These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16315614)

  • 21. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
    Zhang Y; Moore GR; Laule C; Bjarnason TA; Kozlowski P; Traboulsee A; Li DK
    Ann Neurol; 2013 Jul; 74(1):91-9. PubMed ID: 23939554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging the multiple sclerosis lesion: insights into pathogenesis, progression and repair.
    Wang CT; Barnett M; Barnett Y
    Curr Opin Neurol; 2019 Jun; 32(3):338-345. PubMed ID: 30950846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuropathology of multiple sclerosis.
    Ludwin SK
    Neuroimaging Clin N Am; 2000 Nov; 10(4):625-48 ,vii. PubMed ID: 11359716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A real-time insight into disease progression and the role of axonal injury in multiple sclerosis.
    Bjartmar C; Kidd G; Ransohoff RM
    Arch Neurol; 2001 Jan; 58(1):37-9. PubMed ID: 11176934
    [No Abstract]   [Full Text] [Related]  

  • 29. Remyelination in multiple sclerosis.
    Piaton G; Williams A; Seilhean D; Lubetzki C
    Prog Brain Res; 2009; 175():453-64. PubMed ID: 19660673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructure of multiple sclerosis.
    Rodriguez M; Scheithauer B
    Ultrastruct Pathol; 1994; 18(1-2):3-13. PubMed ID: 8191643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of remyelination.
    Barkhof F
    Mult Scler; 1997 Apr; 3(2):129-32. PubMed ID: 9291166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter involvement after TBI: Clues to axon and myelin repair capacity.
    Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM
    Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model.
    Anastasiadou S; Liebenehm S; Sinske D; Meyer zu Reckendorf C; Moepps B; Nordheim A; Knöll B
    Glia; 2015 Jun; 63(6):958-76. PubMed ID: 25639799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis.
    Pendlebury ST; Lee MA; Blamire AM; Styles P; Matthews PM
    Magn Reson Imaging; 2000 May; 18(4):369-78. PubMed ID: 10788713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
    Vargas WS; Monohan E; Pandya S; Raj A; Vartanian T; Nguyen TD; Hurtado Rúa SM; Gauthier SA
    Neuroimage Clin; 2015; 9():369-75. PubMed ID: 26594620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative magnetic resonance mapping of the myelin bilayer reflects pathology in multiple sclerosis brain tissue.
    Baadsvik EL; Weiger M; Froidevaux R; Faigle W; Ineichen BV; Pruessmann KP
    Sci Adv; 2023 Aug; 9(32):eadi0611. PubMed ID: 37566661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.